Ameriprise’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.71M | Buy |
285,004
+78,039
| +38% | +$743K | ﹤0.01% | 2764 |
|
|
2025
Q1 | $2.16M | Sell |
206,965
-12,670
| -6% | -$133K | ﹤0.01% | 2835 |
|
|
2024
Q4 | $5.17M | Buy |
219,635
+6,735
| +3% | +$159K | ﹤0.01% | 2324 |
|
|
2024
Q3 | $7.65M | Buy |
212,900
+186,872
| +718% | +$6.71M | ﹤0.01% | 2039 |
|
|
2024
Q2 | $919K | Buy |
+26,028
| New | +$919K | ﹤0.01% | 3188 |
|
|
2023
Q3 | – | Sell |
-13,300
| Closed | -$150K | – | 3903 |
|
|
2023
Q2 | $150K | Sell |
13,300
-36,211
| -73% | -$407K | ﹤0.01% | 3767 |
|
|
2023
Q1 | $570K | Buy |
49,511
+26,291
| +113% | +$303K | ﹤0.01% | 3379 |
|
|
2022
Q4 | $269K | Hold |
23,220
| – | – | ﹤0.01% | 3619 |
|
|
2022
Q3 | $295K | Buy |
+23,220
| New | +$295K | ﹤0.01% | 3585 |
|